BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23800422)

  • 41. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.
    Zidi S; Gazouani E; Stayoussef M; Mezlini A; Ahmed SK; Yacoubi-Loueslati B; Almawi WY
    Cytokine; 2015 Dec; 76(2):343-347. PubMed ID: 26076679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population.
    Huang SQ; Zhou ZX; Zheng SL; Liu DD; Ye XH; Zeng CL; Han YJ; Wen ZH; Zou XQ; Wu J; Liu YM; Huang CC; Wang Y; Yang G; Jing CX
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29853562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions.
    Trugilo KP; Cebinelli GCM; Berti FCB; Okuyama NCM; Cezar-Dos-Santos F; Sena MM; Mangieri LFL; Watanabe MAE; de Oliveira KB
    Med Microbiol Immunol; 2019 Feb; 208(1):49-58. PubMed ID: 30167873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
    Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
    Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of HPV infection in women at risk in Western Algeria.
    Masdoua N; Boublenza L; Hassaine H; Ngou J; Nahet A; Segondy M; Razik F; Regagba D; Sadouki N; Mouhammedi D
    Med Mal Infect; 2017 Feb; 47(1):38-41. PubMed ID: 27765475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
    Mehta AM; Mooij M; Branković I; Ouburg S; Morré SA; Jordanova ES
    J Immunol Res; 2017; 2017():8913860. PubMed ID: 28280748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women.
    Datta A; Tuz Zahora F; Abdul Aziz M; Sarowar Uddin M; Ferdous M; Shalahuddin Millat M; Shahid Sarwar M; Abdul Barek M; Jafrin S; Nahar S; Safiqul Islam M
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107091. PubMed ID: 33069925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions.
    Mangieri LFL; Sena MM; Cezar-Dos-Santos F; Trugilo KP; Okuyama NCM; Pereira ÉR; Maria GCQ; Watanabe MAE; de Oliveira KB
    Int J Immunogenet; 2019 Oct; 46(5):331-338. PubMed ID: 31183980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide association study of HPV-associated cervical cancer in Japanese women.
    Miura K; Mishima H; Kinoshita A; Hayashida C; Abe S; Tokunaga K; Masuzaki H; Yoshiura K
    J Med Virol; 2014 Jul; 86(7):1153-8. PubMed ID: 24700089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.
    Tsai CW; Chang WS; Lin KC; Shih LC; Tsai MH; Hsiao CL; Yang MD; Lin CC; Bau DT
    Anticancer Res; 2014 Jul; 34(7):3731-7. PubMed ID: 24982395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-G 3' untranslated region polymorphisms influence the susceptibility for human papillomavirus infection.
    Xu HH; Shi WW; Lin A; Yan WH
    Tissue Antigens; 2014 Aug; 84(2):216-22. PubMed ID: 24758208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.
    Bahls L; Yamakawa R; Zanão K; Alfieri D; Flauzino T; Delongui F; de Abreu A; Souza R; Gimenes F; Reiche E; Borelli S; Consolaro M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.
    Botezatu A; Socolov D; Iancu IV; Huica I; Plesa A; Ungureanu C; Anton G
    J Cell Mol Med; 2013 Apr; 17(4):543-9. PubMed ID: 23444906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population.
    Xiao D; Huang W; Ou M; Guo C; Ye X; Liu Y; Wang M; Zhang B; Zhang N; Huang S; Zang J; Zhou Z; Wen Z; Zeng C; Wu C; Huang C; Wei X; Yang G; Jing C
    Oncotarget; 2016 Dec; 7(51):84228-84238. PubMed ID: 27705945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction Between Susceptibility Loci in
    Xiao D; Liu D; Wen Z; Huang X; Zeng C; Zhou Z; Han Y; Ye X; Wu J; Wang Y; Guo C; Ou M; Huang S; Huang C; Wei X; Yang G; Jing C
    Cancer Prev Res (Phila); 2019 Jan; 12(1):57-66. PubMed ID: 30463990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias.
    Cordeiro JC; da Silva JS; Roxo VS; da Graça Bicalho M
    Hum Immunol; 2017 Mar; 78(3):281-286. PubMed ID: 27998803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of Association between IFNL3 Polymorphism and Human Papillomavirus Infection and Their Progression in HIV-Infected Women Receiving Antiretroviral Treatment.
    Ouladlahsen A; Bensghir R; Baba H; Haddaji A; Abbadi I; Zaidane I; Badi H; Sodqi M; Marih L; Wakrim L; Marhoum El Filali K; Benjelloun S; Ezzikouri S
    Pathobiology; 2020; 87(4):262-267. PubMed ID: 32428907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.
    Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Chinchai T; Poovorawan Y
    Asian Pac J Cancer Prev; 2013; 14(1):341-6. PubMed ID: 23534750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of
    Zhang C; Yang Z; Luo P; Ye M; Gong P; Gong Q; Mei B
    Biomark Med; 2023 Feb; 17(3):133-142. PubMed ID: 37097031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A -819 C/T polymorphism in the interleukin-10 promoter is associated with persistent HBV infection, but -1082 A/G and -592A/C polymorphisms are not: a meta-analysis.
    Ren H; Zhang TT; Hu WL
    Arch Virol; 2015 Mar; 160(3):747-56. PubMed ID: 25583543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.